Cargando…

Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis

Detalles Bibliográficos
Autores principales: Ducloux, Didier, Colladant, Mathilde, Chabannes, Melchior, Yannaraki, Maria, Courivaud, Cécile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243640/
https://www.ncbi.nlm.nih.gov/pubmed/34216675
http://dx.doi.org/10.1016/j.kint.2021.06.025
_version_ 1783715786791059456
author Ducloux, Didier
Colladant, Mathilde
Chabannes, Melchior
Yannaraki, Maria
Courivaud, Cécile
author_facet Ducloux, Didier
Colladant, Mathilde
Chabannes, Melchior
Yannaraki, Maria
Courivaud, Cécile
author_sort Ducloux, Didier
collection PubMed
description
format Online
Article
Text
id pubmed-8243640
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Society of Nephrology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-82436402021-07-01 Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis Ducloux, Didier Colladant, Mathilde Chabannes, Melchior Yannaraki, Maria Courivaud, Cécile Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2021-09 2021-06-30 /pmc/articles/PMC8243640/ /pubmed/34216675 http://dx.doi.org/10.1016/j.kint.2021.06.025 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Ducloux, Didier
Colladant, Mathilde
Chabannes, Melchior
Yannaraki, Maria
Courivaud, Cécile
Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis
title Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis
title_full Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis
title_fullStr Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis
title_full_unstemmed Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis
title_short Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis
title_sort humoral response after 3 doses of the bnt162b2 mrna covid-19 vaccine in patients on hemodialysis
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243640/
https://www.ncbi.nlm.nih.gov/pubmed/34216675
http://dx.doi.org/10.1016/j.kint.2021.06.025
work_keys_str_mv AT duclouxdidier humoralresponseafter3dosesofthebnt162b2mrnacovid19vaccineinpatientsonhemodialysis
AT colladantmathilde humoralresponseafter3dosesofthebnt162b2mrnacovid19vaccineinpatientsonhemodialysis
AT chabannesmelchior humoralresponseafter3dosesofthebnt162b2mrnacovid19vaccineinpatientsonhemodialysis
AT yannarakimaria humoralresponseafter3dosesofthebnt162b2mrnacovid19vaccineinpatientsonhemodialysis
AT courivaudcecile humoralresponseafter3dosesofthebnt162b2mrnacovid19vaccineinpatientsonhemodialysis